Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.17%, DAX30 +0.60%, CAC40 +0.30%

Jun 27 ,2025

  • Synopsis

    • European equity markets are set for firmer open as Asian equity markets trade mixed. Japan outperforming with Nikkei nearing 13-month high. Korea pulling back while Greater China, Australia and Taiwan little changed.

    • US equities were higher in Thursday trading. Stocks ended near best levels with major averages on pace for solid weekly gains. S&P 500 and Nasdaq both ended less than 0.1% from record closes.

    • Comments from European Commission President von der Leyen, who said they were assessing the latest US tariff offer. EU leaders discussed Thursday whether to accept a quick deal rather than holding out for a perfect one, even if that means that some tariffs remain in place. Reports highlighted that Brussels is considering lower tariffs on some US imports to reach a quick deal.

    • In central banks, Bank of France's Villeroy speech at award ceremony and presentation of report on banking inclusion. Bank of Portugal economic forum at 11:00CET on challenges in the analysis of public finances in Portugal. Bank of Finland's Rehn speech at 13:00CET and fireside chat at 14:00 at conf jointly hosted with ESRB on AI (through Sat). Norway PM Støre semi-annual summary press conf at 11:00CET. Germany's Chancellor Merz hosts Austrian Chancellor Stocker, a joint press conf. is planned afterward.

    • On economic front, French and Spanish inflation data due, Italian business confidence and Eurozone economic sentiment data also on the agenda.

    • Also, UK Q1 final GDP, Italy, Denmark May retail sales, Norway May retail sales, Sweden May PPI, Belgium Jun CPI, Ireland May retail sales

    • In corporate news: (TIBN.SW) Bergbahnen Engelberg-Trübsee-Titlis reports H1 net income CHF3.8M vs year-ago CHF10.5M

  • Politics/Macro/World News

    • EU leaders discuss new US trade proposal as deal clock ticks down (Reuters )

    • BoE urged to curb bond sales investors say could 'reignite' sell-off (FT )

    • EU Weighs Price of Uneven US Trade Deal (BBG )

  • Top company news

    • Earnings/updates

      • FLOW.NA (Flow Traders) -- 2Q 2025 pre-close call: Market trading volumes and volatility increased in Q2 across most asset classes and regions

    • M&A

      • AKZA.NA (Akzo Nobel) -- to sell up to 75% of AkzoNobel India to JSW Group, expects €900M in net cash

      • ULVR.LN (Unilever) -- paying $1.5B (€1.28B) for Dr Squatch - FT

      • SIKA.SW (Sika Group) -- Sika acquires Qatar-based construction chemicals company Gulf Additive Factory LLC; price not disclosed

      • IMCD.NA (IMCD) -- acquires 100% of shares in Trichem Healthcare Private Limited, Trichem Lifesciences Limited and Chemistry & Health FZ LLC

      • B8FK.GR (Biofrontera AG) -- provides update on negotiations with Biofrontera Inc.; disclose agreement on extension of Biofrontera Inc. payment deferral

      • BRNK.GR (Branicks Group) -- sells two office buildings in Cologne's Rheinauhafen; purchase price not disclosed

      • TRACT.FP (Teract) -- announces it is refocusing on its core businesses and reorganizing

      • +STRB.LN (Starling Bank) -- reportedly eyes acquisition of nationally chartered US bank to continue expansion - Bloomberg

      • (NULL) SembCorp Industries, Serentica Renewables, PE players in running to acquire Macquarie's Vibrant Energy - Mint (05:55 IST / 07:30 SGT)

    • Healthcare

      • NOVN.SW (Novartis) -- Profound Therapeutics announces multi-year collaboration with Novartis to develop therapeutics for cardiovascular disease (pre-open)

      • SWTX (Springworks Therapeutics) -- shareholder approve merger agreement with Merck KGaA - 8-K

    • Other

      • DSFIR.NA (DSM-Firmenich) -- share repurchase program will be increased to €1,080M

      • UNI.IM (Unipol Gruppo) -- Unipol accepts voluntary exchange offer by BPER Banca

      • UNI.SM (Unicaja Banco) -- to implement €2M share buyback

      • DHG.ID (Dalata Hotel Group) -- has completed the Acquisition of the Radisson Blu Hotel Dublin Airport.

  • Key rating changes

    • Upgrades

      • Macquarie upgrades OBM.AU; downgrades A11.AU, ALL.LN, CRN.AU, LTR.AU, MIN.AU, NIC.AU

      • ISM (Indra Sistemas) -- to overweight from equal-weight at Morgan Stanley

      • MTRS.SS (Munters Group) -- to buy from hold at DNB Carnegie

    • Initiations

      • HEM.SS (Hemnet Group) -- sell at UBS

  • Data

    • Nikkei +1.46% to 40163.84

    • Hang Seng (0.25%) to 24265.79

    • Shanghai Composite (0.30%) to 3437.97

    • S&P futures +7.8 vs prior close of 6195.0

    • €-$ (0.0013) or (0.11%) to 1.1691

    • $-¥ +0.06 or +0.04% to 144.46

    • €-¥ (0.07) or (0.04%) to 168.88

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE